Pharmaceutical industry

An Institutional review board (IRB) is an appropriately constituted group that has been designated to review and monitor biomedical research involving human subjects. In accordance with FDA regulations, an IRB has the authority to approve, require modifications in or disapprove research. It serves an important role in the protection of the rights and welfare of human research subjects. The purpose of IRB review is to assure that appropriate steps are taken to protect the rights and welfare of humans

Elisabeth Rosenthal, a non-practicing doctor and reporter for New York Times writes, “The Soaring Cost of a Simple Breath”(2013), which describes the effect the high-cost of pharmaceutical drugs has on a patient's ability to access that drug and the reasons for that high cost. To start, Rosenthal describes a real-life situation involving two girls who rely heavily on the Asthma medication Albuterol to be able to function normally. She uses the context of these individuals to describe the wide range

other therapies. This new drug, Repatha, will cost those who use it $14,100 a year. HIGH PRICE OF REPATHA HAS CAUSED COMMOTION AMONG DRUG COMPANIES This high price tag has caused quite a commotion among some of the other drug companies in the industry. Express Scripts Holding Co., one of the country’s largest manager of prescription drug benefits, say that up to 10 million people are affected by extremely high levels of cholesterol. According to them, this new class of drugs to treat them has

Did you realize that upper medications speak to a $10 billion dollar advertise in the U.S. alone? These medications depend on the concoction awkwardness hypothesis assuming that low serotonin levels can bring about uneasiness and depressive issue. Be that as it may, the compound lopsidedness hypothesis as a reason for nervousness and depressive issue never was valid. Indeed, no test has ever demonstrated that anybody has a "lopsidedness" of any neurotransmitters or some other cerebrum chemicals.

Chronic intake, delayed onset of action, drug resistance and numerous side effects of current antidepressants have forced researchers to look for new and safer drugs (1, 2) with rapid onset and longer acting times. Results obtained in recent years have been encouraging especially with ketamine a global NMDAR antagonist. The antidepressant-like activity of ketamine has been shown in many preclinical studies (1–7). A single non-anesthetic dose of ketamine reversed the symptoms of major depression

alarming decline has transpired in the development and research of new antimicrobial treatments to deal with the increasing threat. Despite recent attempts by US Congress in 2005 to introduce legislation that seemed to spotlight weaknesses with pharmaceutical investments in antimicrobial research, the legislation was not enacted. In the meantime, more microorganisms continue to become more resistant to treatments, and the majority of the public are unaware of this detrimental trend. In this paper

USA is the leader in Pharmaceutical industry. It can be noted that more than 80% of the total worlds research and development takes place in USA. Even most of the patents or highest numbers of patents are held by companies in USA. It employs about 272,000 people (source: Bureau of Labour Statistics).Even the bestselling drug in the world “Lipitor” which is a cholesterol drug is Produced by Pfizer which is a US company. Incidentally Pfizer is also world‟s largest Pharmaceutical Company. Pfizer has

Tevapharma (2014) defines to Teva as "a global company specializing in the development, production and marketing of generic drugs and innovative". Teva is in the top 10 companies pharmaceutical world and is the company number 1 in medicines generic. ! The headquarters of Teva is located in Israel, divided in approximately 60 countries and with a figure of 46 employees, it has earned to be the first company in the world in generic medicines as the development, production and commercialization of a

including leading pharmaceutical companies. A collaborator paid an upfront fee, agreed to payments as the drug development program reached

safe and effective. This is achieved through the regulation and supervision of food safety, dietary supplements, veterinary products, cosmetics, vaccines, biopharmaceuticals, medical devices, prescription and pharmaceutical drugs that can be purchased over- the- counter. When a pharmaceutical company creates a new drug, it has to go through the FDA and is required to submit a New Drug Application (NDA) to the FDA. The FDA reviews the application to assure that there is an objective proof that the